Economy

Earnings Analysis Of Boston Scientific Corporation (BSX)

Orbimed Advisors Llc sold 911,400 shares as the company's stock rose 4.02% with the market. The company's stock had a trading volume of 20,667,506 shares, compared to its average volume of 6,852,641. Boston Scientific Corp now has $35.91 billion valuation.

The stock decreased 2.03% or $0.53 during the last trading session, reaching $25.62. Below is a list of Boston Scientific Corporation (NYSE:BSX) latest ratings and price target changes.

Jennison Associates Llc increased Clovis Oncology Inc (CLVS) stake by 222.5% reported in 2017Q2 SEC filing. In the last 90 days, insiders sold 414,698 shares of company stock valued at $12,013,153. About 1.38M shares traded. It has outperformed by 266.01% the S&P500.

Among 3 analysts covering Rolls Royce PLC (OTCMKTS:RYCEY), 1 have Buy rating, 1 Sell and 1 Hold.

Investors sentiment decreased to 1.81 in Q2 2017. Its up 0.14, from 0.89 in 2017Q1. 74 funds opened positions while 87 raised stakes. Duncker Streett & holds 839 shares. (NASDAQ:CLVS) for 160,653 shares. Guardian Life Insurance Com Of America reported 3,097 shares. Sun Life Inc holds 10,012 shares or 0.03% of its portfolio. Franklin Resource invested 0.08% of its portfolio in Clovis Oncology, Inc.

In the most updated research from a number of analysts on Wall Street, the company gets 19 Buys and 0 Sell among 24 analysts. JP Morgan maintained the shares of BSX in report on Friday, July 29 with "Overweight" rating. Fdx stated it has 16,798 shares or 0.01% of all its holdings. Royal Commercial Bank Of Canada invested in 59,694 shares or 0% of the stock. Tci Wealth, a Arizona-based fund reported 2,561 shares. 20,000 are owned by Sivik Limited Co. Cleararc Capital holds 0.15% or 33,576 shares. Airain Ltd has 15,235 shares for 0.02% of their portfolio. Anchor Cap Advsr Ltd owns 832,353 shares. Analysts had predicted $0.31. Therefore 70% are positive. The firm has "Underperform" rating by Bernstein given on Tuesday, December 8. The firm earned "Hold" rating on Monday, May 9 by WallachBeth Capital. The company was maintained on Monday, July 31 by Leerink Swann.

More news: Apple Improves HDR Frame Rate Settings in Apple TV tvOS 11.2 Update

BTIG Research upgraded shares of Boston Scientific (NYSE:BSX) from a neutral rating to a buy rating in a research report sent to investors on Thursday, MarketBeat reports. They expect $0.34 earnings per share, up 13.33 % or $0.04 from last year's $0.3 per share. BSX's profit will be $466.88M for 18.60 P/E if the $0.34 EPS becomes a reality.

Boston Scientific Corporation most recently reported earnings per share (EPS) of $0.31 for the September 2017 versus $0.27 in the same quarter a year ago, representing 15% growth. Of those transactions, there were 710,384 shares of BSX bought and 1.74 million shares sold. 56 funds opened positions while 165 raised stakes. Boston Scientific earned a media sentiment score of 0.39 on Accern's scale. Private Trust Na holds 0.29% or 47,878 shares. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since December 4, 2016 and is uptrending.

The stock of Boston Scientific Corporation (NYSE:BSX) is a huge mover today! Greenwood Assocs Ltd accumulated 0.38% or 53,330 shares. Gulf International Bancorp (Uk) Ltd accumulated 0.16% or 416,265 shares. Twin Tree Mgmt Limited Partnership reported 0.03% stake. Highland Capital Ltd Llc invested in 10,490 shares. Steward Partners Investment Advisory LLC acquired a new stake in shares of Boston Scientific in the third quarter worth approximately $139,000. San Francisco Sentry (Ca) owns 6,882 shares or 0.07% of their USA portfolio.

Since June 1, 2017, it had 0 insider purchases, and 1 insider sale for $379,736 activity. Pierce David A had sold 13,562 shares worth $379,736 on Friday, June 9. On average, equities research analysts anticipate that Boston Scientific will post $1.25 EPS for the current year. Therefore 82% are positive. The company had revenue of $2.22 billion during the quarter, compared to analysts' expectations of $2.21 billion. Canaccord Genuity reduced their price target on Boston Scientific from $36.00 to $35.00 and set a "buy" rating for the company in a research report on Wednesday, November 29th. As per Thursday, June 9, the company rating was initiated by Guggenheim. The firm has "Buy" rating given on Thursday, February 25 by SunTrust.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: Prnewswire.com which released: "Boston Scientific To Participate In Citi 2017 Global Healthcare Conference" on November 27, 2017, also Prnewswire.com with their article: "Boston Scientific To Participate In 26th Annual Credit Suisse Healthcare ..." published on November 06, 2017, Globenewswire.com published: "Global Wearable Computing Market 2017-2022 with Medtronic, Garmin, Boston ..." on November 17, 2017. BMO Capital Markets has "Outperform" rating and $32 target. The firm has "Neutral" rating by Wedbush given on Thursday, April 28. On Wednesday, October 28 the stock rating was maintained by Needham with "Buy".



Like this

loading...
loading...

Latest


05 December 2017
Fugitive Eastern KY attorney Eric Conn captured in Honduras
Authorities in Honduras have captured a Kentucky disability lawyer who was one of the FBI's Most Wanted. Conn was wanted after he and co-conspirators stole more than $500,000 in social security funds.

05 December 2017
Australia's central bank keeps rates on hold
If rates were to rise - however imperceptibly - millions of Australian households paying off a mortgage would experience the pinch.

05 December 2017
Cooper Tire & Rubber (CTB) Stock Rating Upgraded by ValuEngine
Albert increased its stake in Cf Inds Hldgs Inc (CF) by 26.69% based on its latest 2017Q2 regulatory filing with the SEC. The stock has a market capitalization of $1,863.80, a PE ratio of 9.37, a P/E/G ratio of 1.18 and a beta of 0.07.

05 December 2017
President Emmerson Mnangagwa swears in New cabinet members
Zimbabwes President Emmerson Mnangagwa , left, swears ministers at State House in Harare, Monday, December, 4, 2017. We did so in the genuine, perhaps naive view that the country could actually move forward.

05 December 2017
Trading Notes on GNC Holdings, Inc. (NYSE:GNC): Active Stock Recap
Baird reaffirmed a "hold" rating and set a $10.00 price objective on shares of GNC in a research report on Sunday, September 17th. State Board Of Administration Of Florida Retirement Systems has 0% invested in GNC Holdings, Inc. (NYSE: GNC ) for 80,181 shares.

05 December 2017
Dick's Sporting Goods (DKS) Given New $25.00 Price Target at Buckingham Research
Finally, Hatteras Funds LP purchased a new stake in shares of Dicks Sporting Goods during the fourth quarter worth about $262,000. The sporting goods retailer reported $0.30 EPS for the quarter, beating analysts' consensus estimates of $0.26 by $0.04.

05 December 2017
Selena Gomez Accidentally Bares Her Nip After Debuting Multiple Looks In London!
Ahead, admire Selena's fancy London attire , then shop her kicks and wear them with denim and a breezy blouse. Selena's black and white look is Proenza Schouler .

05 December 2017
Some Stocks within Concentration: Adobe Systems Incorporated (ADBE), Rio Tinto plc (RIO)
With 159,400 avg volume, 13 days are for Malibu Boats Class A (NASDAQ:MBUU)'s short sellers to cover MBUU's short positions. In related news, EVP Ann Lewnes sold 1,953 shares of the firm's stock in a transaction dated Wednesday, September 13th.

05 December 2017
How Analysts Feel About Ulta Beauty, Inc. (NASDAQ:ULTA)?
Ulta Beauty, Inc. ( ULTA ) shares are up 1.05% for the week and that has got investors and traders sitting up and taking note. Wall Street is only getting more bullish on the stock, with 12 of analysts who cover ULTA having a buy-equivalent rating.

05 December 2017
Washington State's Falk wins Burlsworth Trophy
Mayfield's Burlsworth Trophy loss comes after a season where he led the Sooners to 12 wins and a Big 12 Championship. Washington State (9-3) is scheduled to play Michigan State in the Holiday Bowl on December 28.